Darya-Varia Laboratoria Tbk - Asset Resilience Ratio
Darya-Varia Laboratoria Tbk (DVLA) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Darya-Varia Laboratoria Tbk to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Darya-Varia Laboratoria Tbk's Asset Resilience Ratio has changed over time. See Darya-Varia Laboratoria Tbk balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Darya-Varia Laboratoria Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Darya-Varia Laboratoria Tbk.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Darya-Varia Laboratoria Tbk maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Darya-Varia Laboratoria Tbk Industry Peers by Asset Resilience Ratio
Compare Darya-Varia Laboratoria Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Bausch Health Companies Inc
TO:BHC |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.15% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Hainan Haiyao Co Ltd
SHE:000566 |
Drug Manufacturers - Specialty & Generic | 3.27% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Darya-Varia Laboratoria Tbk (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Darya-Varia Laboratoria Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | Rp0.00 ≈ $0.00 |
Rp2.16 Trillion ≈ $126.66 Million |
-- |
| 2023-12-31 | 0.64% | Rp13.00 Billion ≈ $761.75K |
Rp2.04 Trillion ≈ $119.66 Million |
+2.75pp |
| 2022-12-31 | -2.11% | Rp-42.43 Billion ≈ $-2.49 Million |
Rp2.01 Trillion ≈ $117.73 Million |
+0.05pp |
| 2021-12-31 | -2.16% | Rp-45.04 Billion ≈ $-2.64 Million |
Rp2.09 Trillion ≈ $122.23 Million |
-2.79pp |
| 2020-12-31 | 0.63% | Rp12.59 Billion ≈ $737.60K |
Rp1.99 Trillion ≈ $116.41 Million |
+4.82pp |
| 2019-12-31 | -4.19% | Rp-76.61 Billion ≈ $-4.49 Million |
Rp1.83 Trillion ≈ $107.23 Million |
-8.88pp |
| 2018-12-31 | 4.69% | Rp79.00 Billion ≈ $4.63 Million |
Rp1.68 Trillion ≈ $98.61 Million |
-14.08pp |
| 2017-12-31 | 18.77% | Rp308.00 Billion ≈ $18.05 Million |
Rp1.64 Trillion ≈ $96.15 Million |
+18.27pp |
| 2016-12-31 | 0.50% | Rp7.71 Billion ≈ $451.51K |
Rp1.53 Trillion ≈ $89.73 Million |
+0.04pp |
| 2015-12-31 | 0.47% | Rp6.43 Billion ≈ $376.59K |
Rp1.38 Trillion ≈ $80.64 Million |
+0.06pp |
| 2014-12-31 | 0.41% | Rp5.08 Billion ≈ $297.92K |
Rp1.24 Trillion ≈ $72.44 Million |
-0.14pp |
| 2013-12-31 | 0.55% | Rp6.50 Billion ≈ $381.07K |
Rp1.19 Trillion ≈ $69.73 Million |
+0.27pp |
| 2012-12-31 | 0.28% | Rp3.01 Billion ≈ $176.36K |
Rp1.07 Trillion ≈ $62.97 Million |
+0.03pp |
| 2009-12-31 | 0.25% | Rp1.98 Billion ≈ $115.90K |
Rp783.61 Billion ≈ $45.92 Million |
+0.08pp |
| 2008-12-31 | 0.17% | Rp1.08 Billion ≈ $63.51K |
Rp637.66 Billion ≈ $37.36 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more